Paratek Pharma Inc
(PRTK)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,695 | -20,143 | -63,566 | -56,409 | -35,527 |
| Depreciation Amortization | 93 | 47 | 490 | 404 | 275 |
| Accounts receivable | 34,901 | 34,030 | -40,424 | 2,023 | 187 |
| Other Working Capital | 37,318 | 28,011 | -20,791 | -4,413 | -7,436 |
| Other Operating Activity | -28,303 | -30,855 | 58,150 | 12,367 | 8,892 |
| Operating Cash Flow | $9,314 | $11,090 | $-66,141 | $-46,028 | $-33,609 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 0 | 14,840 | -15,160 | -15,160 |
| PPE Investments | -32 | -32 | -36 | -36 | -36 |
| Investing Cash Flow | $-32 | $-32 | $14,804 | $-15,196 | $-15,196 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -845 | -280 | -2,888 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 7,981 | 7,819 | 7,818 |
| Financing Cash Flow | $-845 | $-280 | $5,093 | $7,819 | $7,818 |
| Beginning Cash Position | 34,373 | 34,373 | 80,617 | 80,617 | 80,617 |
| End Cash Position | 42,810 | 45,151 | 34,373 | 27,212 | 39,630 |
| Net Cash Flow | $8,437 | $10,778 | $-46,244 | $-53,405 | $-40,987 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,314 | 11,090 | -66,141 | -46,028 | -33,609 |
| Capital Expenditure | -32 | -32 | -36 | -36 | -36 |
| Free Cash Flow | 9,282 | 11,058 | -66,177 | -46,064 | -33,645 |